TriSalus Life Sciences annual total assets
2020
2021
2022
2023
2024
2025
TriSalus Life Sciences Total Assets Growth & History (TLSI)
TriSalus Life Sciences's total assets was $35.3M for fiscal 2025.
View full TriSalus Life Sciences company overviewTriSalus Life Sciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $35.3M | $11.4M | +47.39% |
| 2024 | 2024-12-31 | $24.0M | −$627,000 | −2.55% |
| 2023 | 2023-12-31 | $24.6M | $2.6M | +11.83% |
| 2022 | 2022-12-31 | $22.0M | −$228.5M | −91.22% |
| 2021 | 2021-12-31 | $250.5M | −$1.5M | −0.59% |
| 2020 | 2020-12-31 | $252.0M | — | — |
TriSalus Life Sciences quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $62.4M | $21.1M | +51.14% |
| Q1 2026 | 2026-03-31 | $71.0M | $42.4M | +147.96% |
| Q4 2025 | 2025-12-31 | $35.3M | $11.4M | +47.39% |
| Q3 2025 | 2025-09-30 | $36.5M | $9.0M | +32.70% |
| Q2 2025 | 2025-06-30 | $41.3M | $8.9M | +27.40% |
| Q1 2025 | 2025-03-31 | $28.6M | $10.7M | +60.01% |
| Q4 2024 | 2024-12-31 | $24.0M | −$627,000 | −2.55% |
| Q3 2024 | 2024-09-30 | $27.5M | −$6.1M | −18.11% |
| Q2 2024 | 2024-06-30 | $32.4M | $20.2M | +165.01% |
| Q1 2024 | 2024-03-31 | $17.9M | −$2.6M | −12.82% |
| Q4 2023 | 2023-12-31 | $24.6M | $2.6M | +11.83% |
| Q3 2023 | 2023-09-30 | $33.6M | −$217.8M | −86.65% |
| Q2 2023 | 2023-06-30 | $12.2M | −$238.3M | −95.12% |
| Q1 2023 | 2023-03-31 | $20.5M | −$229.9M | −91.81% |
| Q4 2022 | 2022-12-31 | $22.0M | −$228.5M | −91.22% |
| Q3 2022 | 2022-09-30 | $251.3M | $563,313 | +0.22% |
| Q2 2022 | 2022-06-30 | $250.6M | −$653,152 | −0.26% |
| Q1 2022 | 2022-03-31 | $250.4M | −$1.4M | −0.55% |
| Q4 2021 | 2021-12-31 | $250.5M | −$1.5M | −0.59% |
| Q3 2021 | 2021-09-30 | $250.8M | — | — |
| Q2 2021 | 2021-06-30 | $251.2M | — | — |
| Q1 2021 | 2021-03-31 | $251.8M | — | — |
| Q4 2020 | 2020-12-31 | $252.0M | — | — |
TriSalus Life Sciences total assets trends
Over the last five fiscal years, TriSalus Life Sciences's total assets decreased from $252.0M to $35.3M, a change of −$216.7M. The latest reported quarter, Q2 2026, shows $62.4M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TriSalus Life Sciences source filings ↗